Furthermore, tumor endothelium may contribute to immune escape through expression of receptors that inhibit T cell activation (e.g., PD-L1, PD-L2) (30) and FasL expression, which preferentially kills CD8+ T cells but not Tregs (31). This evidence concerns the gene PDCD1LG2 and neoplasm.